FDA Adverse Event Injury Summary report: N

CONSEPT 1 STEP

MDR report key: 13463734 · Received February 4, 2022

Report

Report Number
3012236936-2022-00205
Event Type
Injury
Date Received
February 4, 2022
Date of Event
January 2, 2022
Report Date
April 10, 2022
Manufacturer
AMO(HANGZHOU) CO., LTD.
Product Code
LPN
PMA / PMN Number
P850088
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT RETURNED FOR EVALUATION. THEREFORE, A VISUAL ANALYSIS OF THE COMPLAINT DEVICE CANNOT BE COMPLETED. A REVIEW OF THE DEVICE HISTORY RECORD, COMPLAINT TRENDING, AND RISK DOCUMENTATION FOR THIS DEVICE WILL BE PERFORMED. UPON COMPLETION OF THE REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION A SUPPLEMENTAL MEDWATCH WILL BE FILED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC., HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT RETURNED FOR EVALUATION. THEREFORE, A VISUAL ANALYSIS OF THE COMPLAINT DEVICE CANNOT BE COMPLETED. A REVIEW OF THE DEVICE HISTORY RECORD, COMPLAINT TRENDING, AND RISK DOCUMENTATION FOR THIS DEVICE WILL BE PERFORMED. UPON COMPLETION OF THE REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION A SUPPLEMENTAL MEDWATCH WILL BE FILED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC., HAS BEEN SUBMITTED.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION SECTION D9: DEVICE AVAILABLE FOR EVALUATION? YES. SECTION D9: DATE RETURNED TO MANUFACTURER: FEB 22, 2022. SECTION H3: EVALUATED BY MANUFACTURER: YES. DEVICE EVALUATION: PRODUCT CHEMICAL TEST WAS CONDUCTED TO THE RETURNED SAMPLE, ALL THE TESTED ITEMS MET THE PRODUCT SPECIFICATION, NO PRODUCT DEFICIENCY WAS CONFIRMED. MANUFACTURING RECORD REVIEW: THE MANUFACTURING RECORDS FOR THE PRODUCT WERE REVIEWED. THE PRODUCT WAS MANUFACTURED AND RELEASED ACCORDING TO SPECIFICATIONS. COMPLAINT DATA WAS TRENDED BY THE REPORTED LOT NUMBER: ZJ05556. ONE COMPLAINT WAS REPORTED IN PREVIOUS 12 MONTHS. NO PRODUCT DEFICIENCY WAS CONFIRMED FOR THE SIMILAR ISSUE CONCLUSION: AS A RESULT OF THE INVESTIGATION THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY AND THE REPORTED ISSUE COULD NOT BE VERIFIED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC., HAS BEEN SUBMITTED.

Description of Event or Problem · 0

CONSUMER REPORTED THAT SHE EXPERIENCED IRRITATION IN HER RIGHT EYE WHEN WEARING HER CONTACT LENSES AFTER TAKING CARE OF THEM WITH CONSEPT 1-STEP SOLUTION. REPORTEDLY, THE PRODUCT WAS USED PROPERLY. THE CONTACTS LENSES USED WERE ACUVUE OASYS (BI-WEEKLY). THE BOTTLE WAS NEWLY OPENED AND SO WERE THE CONTACTS, OPENED (B)(6) 2022, AND USED. THE NEXT MORNING (B)(6), THE CONSUMER AGAIN EXPERIENCED IRRITATION WHEN WEARING THE CONTACT LENS. CONSUMER SOUGHT MEDICAL ATTENTION AT AN EYE CLINIC. THE DOCTOR SAID HER CORNEA HAD SMALL SCRATCHES, BUT THE CAUSE WAS UNKNOWN. SHE WAS PRESCRIBED TEARBALANCE OPHTHALMIC SOLUTION 0.1%, AND GATIFLO OPHTHALMIC SOLUTION 0.3%, AND WORE EYEGLASSES. THE SYMPTOMS SUBSIDED. NO FURTHER INFORMATION WAS PROVIDED. THIS REPORT IS FOR THE DISINFECTING SOLUTION. A SEPARATE REPORT IS BEING SUBMITTED FOR THE NEUTRALIZING TABLETS.

Description of Event or Problem · 0

CONSUMER REPORTED THAT SHE EXPERIENCED IRRITATION IN HER RIGHT EYE WHEN WEARING HER CONTACT LENSES AFTER TAKING CARE OF THEM WITH CONSEPT 1-STEP SOLUTION. REPORTEDLY, THE PRODUCT WAS USED PROPERLY. THE CONTACTS LENSES USED WERE ACUVUE OASYS (BI-WEEKLY). THE BOTTLE WAS NEWLY OPENED AND SO WERE THE CONTACTS, OPENED (B)(6) 2022, AND USED. THE NEXT MORNING (B)(6), THE CONSUMER AGAIN EXPERIENCED IRRITATION WHEN WEARING THE CONTACT LENS. CONSUMER SOUGHT MEDICAL ATTENTION AT AN EYE CLINIC. THE DOCTOR SAID HER CORNEA HAD SMALL SCRATCHES, BUT THE CAUSE WAS UNKNOWN. SHE WAS PRESCRIBED TEARBALANCE OPHTHALMIC SOLUTION 0.1%, AND GATIFLO OPHTHALMIC SOLUTION 0.3%, AND WORE EYEGLASSES. THE SYMPTOMS SUBSIDED. NO FURTHER INFORMATION WAS PROVIDED. THIS REPORT IS FOR THE DISINFECTING SOLUTION. A SEPARATE REPORT IS BEING SUBMITTED FOR THE NEUTRALIZING TABLETS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
683446 CONSEPT 1 STEP ACCESSORIES, SOFT LENS PRODUCTS LPN AMO(HANGZHOU) CO., LTD. 7167X ZJ05556

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention TABLET LOT# 90996, ACUVUE OASYS CONTACT LENS